HDAC9 and cardiac hypertrophy: Therefore, the modulation of myocardial hypertrophy based on gene expression pathways for neuraminidase and HDAC inhibitors, RNA preparations, theaflavin, and proton pump inhibitors seems to be promising for translation into practice (Figure 2).